Mumbai, Aug. 29 -- The contract value of Rs 24.06 crore includes packing, forwarding, insurance, and delivery at the consignee site in Afghanistan.
Shukra Pharmaceuticals manufactures and markets pharmaceutical products and does laboratory testing.
The company reported a 110.2% surge in consolidated net profit to Rs 1.03 crore, while revenue from operations rose 69.5% to Rs 5.39 crore in Q1 FY26 over Q1 FY25.
Published by HT Digital Content Services with permission from Capital Market....